TY - JOUR
T1 - Contrast induced nephropathy
T2 - updated ESUR Contrast Media Safety Committee guidelines
AU - Stacul, Fulvio
AU - van der Molen, Aart J
AU - Reimer, Peter
AU - Webb, Judith A W
AU - Thomsen, Henrik S
AU - Morcos, Sameh K
AU - Almén, Torsten
AU - Aspelin, Peter
AU - Bellin, Marie-France
AU - Clement, Olivier
AU - Heinz-Peer, Gertraud
AU - Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR)
PY - 2011/12
Y1 - 2011/12
N2 - PURPOSE: The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced nephropathy (CIN). AREAS COVERED: Topics reviewed include the definition of CIN, the choice of contrast medium, the prophylactic measures used to reduce the incidence of CIN, and the management of patients receiving metformin. Key Points • Definition, risk factors and prevention of contrast medium induced nephropathy are reviewed. • CIN risk is lower with intravenous than intra-arterial iodinated contrast medium. • eGFR of 45 ml/min/1.73 m (2) is CIN risk threshold for intravenous contrast medium. • Hydration with either saline or sodium bicarbonate reduces CIN incidence. • Patients with eGFR = 60 ml/min/1.73 m (2) receiving contrast medium can continue metformin normally.
AB - PURPOSE: The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced nephropathy (CIN). AREAS COVERED: Topics reviewed include the definition of CIN, the choice of contrast medium, the prophylactic measures used to reduce the incidence of CIN, and the management of patients receiving metformin. Key Points • Definition, risk factors and prevention of contrast medium induced nephropathy are reviewed. • CIN risk is lower with intravenous than intra-arterial iodinated contrast medium. • eGFR of 45 ml/min/1.73 m (2) is CIN risk threshold for intravenous contrast medium. • Hydration with either saline or sodium bicarbonate reduces CIN incidence. • Patients with eGFR = 60 ml/min/1.73 m (2) receiving contrast medium can continue metformin normally.
U2 - 10.1007/s00330-011-2225-0
DO - 10.1007/s00330-011-2225-0
M3 - Journal article
SN - 0938-7994
VL - 21
SP - 2527
EP - 2541
JO - European Radiology
JF - European Radiology
IS - 12
ER -